Anuddin, Helen S.
HRN: 21-81-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/16/2022
08/22/2022
IV DRIP
135mg
Q24
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes